Hansoh Biomedical R&d Company
Clinical trials sponsored by Hansoh Biomedical R&d Company, explained in plain language.
-
New cancer drug combo enters human testing for Tough-to-Treat colon cancer
Disease control Not yet recruitingThis clinical trial is testing a new combination treatment called HS-20110 in patients with advanced colorectal cancer that has spread. The study aims to find the safest and most effective dose and see how well the treatment works to control the cancer. It will involve 502 adult …
Phase: PHASE1, PHASE2 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for tough lung cancers: experimental combo challenges standard chemo
Disease control Not yet recruitingThis study is for people with advanced non-squamous non-small cell lung cancer that has worsened after previous treatment. Researchers want to see if a new two-drug combination (HS-20093 plus adebrelimab) works better and is safer than the standard chemotherapy drug docetaxel. Ab…
Phase: PHASE3 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC